Arkolith/Insider Trading/TGTX/Form 4

Weiss Michael S

CEO and President, DirectorTG THERAPEUTICS, INC. (TGTX) · full profile →Form 4 · filed Aug 14, 2023
Net Buying
Open-Market Buys
$1.0M
Open-Market Sells
$0
Net Open-Market Flow
$1.0M
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 11, 2023Buy(P)100K$10.13$1.0M12.1M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-23-091054) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML